Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.96 USD | +0.30% | -1.74% | +54.59% |
Mar. 22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Mar. 21 | William Blair Initiates Neurogene With Outperform Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 385M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -74M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.28
x | P/E ratio 2025 * |
-8.75
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.64% |
Latest transcript on Neurogene Inc.
1 day | +0.30% | ||
1 week | -1.74% | ||
Current month | -41.14% | ||
1 month | -39.18% | ||
3 months | -5.49% | ||
Current year | +54.59% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 29.96 | +0.30% | 47,839 |
24-04-25 | 29.87 | -1.19% | 71,109 |
24-04-24 | 30.23 | -3.02% | 52,572 |
24-04-23 | 31.17 | +1.83% | 58,205 |
24-04-22 | 30.61 | +0.39% | 116,416 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.59% | 385M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NGNE Stock